FAIC Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, FAIC Act, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Environment, Agriculture.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section HBCE0C54CDEC84324A7F472DC95D304C7: 1. Short title This Act may be cited as the Facilitating Access to Innovation in Cancer Care Act or the FAIC Act.
- Section H6A792EECE7AA432F904D8A10AB005977: 2. Separate payment for certain cancer treatments Section 1833(t)(16) of the Social Security Act (42 U.S.C. 1395(t)(16)) is amended by adding at the end the...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, FAIC Act, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Environment, Agriculture
Primary Purpose
This bill, FAIC Act, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
In CommitteeReferred to the Committee on Energy and Commerce, and in …
Introduced in House
Mr. Dunn of Florida (for himself and Mr. Soto) introduced …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → The Secretary identified in the operative section
Key Definitions
Terms defined in this bill
a drug or biological that— is approved by the Food and Drug Administration on or after January 1, 2008, for use in the detection or treatment of cancer
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology